NCT01656551
MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer treatment 3 active_not_recruiting NCT01493011
Chemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT03304093
Immunotherapy by Nivolumab for HIV+ Patients treatment 2 completed NCT04432207
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer treatment 1 active_not_recruiting NCT03396185
Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung Cancer treatment 2 unknown_status NCT03307785
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 treatment 1 active_not_recruiting NCT03288870
Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS) treatment 2 / 3 unknown_status NCT06555263
Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 recruiting NCT01473563
A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Not Available 2 completed NCT06394427
Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT03628144
Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer No drug interventions supportive_care 2 withdrawn NCT02176369
Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial treatment 2 completed NCT00766246
Phase II Avastin Trial for Stage IIIB/IV NSCLC treatment 2 terminated NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03472053
A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT03302247
Depletion of Myeloid Derived Suppressor Cells to Enhance Anti PD-1 Therapy treatment 2 terminated NCT03532698
Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC) Not Available Not Available unknown_status NCT03543683
Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC Not Available Not Available unknown_status NCT02035683
PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy No drug interventions treatment Not Available active_not_recruiting NCT03334071
Exercise Intervention During Chemotherapy in Advanced Lung Cancer Patients No drug interventions treatment Not Available unknown_status NCT01798485
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC treatment 3 terminated NCT05713006
Alectinib Pharmacokinetic in Patients With NSCLC treatment 1 / 2 recruiting NCT01405586
MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer treatment 3 active_not_recruiting NCT01348126
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer treatment 2 / 3 terminated NCT01999673
Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer treatment 3 completed NCT05497973
Psychosocial eHealth in Advanced Lung Cancer No drug interventions supportive_care Not Available recruiting NCT03386929
Survival Prolongation by Rationale Innovative Genomics treatment 1 / 2 terminated NCT06436144
Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC treatment 2 not_yet_recruiting NCT03611738
Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC treatment 1 active_not_recruiting NCT06525246
Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer treatment 1 active_not_recruiting NCT00029003
Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT00078390
Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT02132884
Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer No drug interventions treatment Not Available terminated NCT01854684
Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery treatment 1 completed NCT02581943
Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer treatment 2 completed NCT00369551
Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer treatment 1 terminated NCT01345851
Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery treatment Not Available active_not_recruiting NCT00075751
Gemcitabine, Carboplatin, and Bortezomib in Advanced or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT00976677
Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer treatment 2 terminated NCT01935947
Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer treatment 2 terminated NCT01411098
Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery treatment 1 terminated NCT01014598
Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis treatment 1 completed NCT02621398
Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer treatment 1 active_not_recruiting NCT00068497
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer treatment Not Available completed NCT00118183
Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT01857271
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer treatment 2 terminated NCT00481078
Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT00020709
Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery treatment 3 completed NCT00042315
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) Not Available 3 terminated NCT03048500
Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery treatment 2 unknown_status NCT01557959
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT01806675
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy diagnostic 1 / 2 completed NCT02897375
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors treatment 1 completed NCT00459342
Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT02154399
EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer No drug interventions treatment 2 completed NCT01741636
Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer No drug interventions supportive_care Not Available completed NCT02655913
Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer treatment 1 / 2 completed NCT03049618
Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475 treatment 2 active_not_recruiting NCT03916419
Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT01781741
Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer No drug interventions treatment 0 completed NCT01131234
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT02819024
Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography diagnostic Not Available active_not_recruiting NCT02495896
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors treatment 1 terminated NCT02947386
Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer treatment 1 completed NCT00074022
GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors treatment 1 / 2 completed NCT02243748
Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers No drug interventions supportive_care Not Available completed NCT00387465
Azacitidine and Entinostat in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00986674
Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT00387374
Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab treatment 2 completed NCT00021060
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer treatment 2 / 3 completed NCT06167460
Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC. No drug interventions Not Available Not Available recruiting NCT02879994
Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT02599194
18F-FSPG PET/CT for Cancer Patients on Therapy diagnostic 2 completed NCT00006929
Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer treatment 2 completed NCT00400829
E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT00368992
S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT00098540
Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT02059967
Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC treatment 1 withdrawn NCT00066768
Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer treatment 1 completed NCT01193868
RO4929097 in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Recently Completed Treatment With Front-Line Chemotherapy treatment 2 terminated NCT02073968
PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer treatment 2 completed NCT00040768
Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer treatment 2 terminated NCT01457469
Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer supportive_care 1 completed NCT00003869
Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer treatment 3 completed NCT00499655
Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer treatment 2 completed NCT01707823
Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer basic_science 0 terminated NCT04062708
CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT00005838
Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery treatment 3 completed NCT00138203
Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT03154190
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer No drug interventions health_services_research Not Available unknown_status NCT02823990
TG4010 and Nivolumab in Patients With Lung Cancer treatment 2 completed NCT02566421
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery No drug interventions treatment Not Available terminated NCT00042302
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) Not Available 3 terminated NCT00020202
FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer treatment 2 completed NCT01737502
Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer treatment 1 / 2 completed NCT01282333
Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer treatment 1 terminated NCT00564733
FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer treatment 2 completed NCT04776447
Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) treatment 2 active_not_recruiting NCT02186847
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT00030498
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction treatment 1 completed NCT01711697
An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 1 unknown_status NCT00004883
Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 treatment 2 completed NCT00662311
Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery treatment 1 / 2 terminated NCT00088088
STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT02364609
Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib treatment 1 completed NCT00093756
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00638937
AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy treatment 2 completed NCT01658332
Circulating Tumor Cells in Lung Cancer No drug interventions diagnostic Not Available terminated NCT02245100
Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT00088959
Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 1 completed NCT02106559
Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy treatment Not Available withdrawn NCT01935336
Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers treatment 2 completed NCT00247416
Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer treatment 2 completed NCT01726296
Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care No drug interventions health_services_research Not Available completed NCT02567396
Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction treatment 1 withdrawn NCT02728596
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) No drug interventions health_services_research Not Available completed NCT01155258
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors treatment 1 completed NCT00042835
Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer treatment 1 terminated NCT00079235
CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT02134886
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection treatment 1 terminated NCT02262325
Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery treatment 2 active_not_recruiting NCT02017925
Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing Chemoradiation No drug interventions supportive_care Not Available withdrawn NCT00101348
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00055757
Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT00950365
Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu treatment 1 completed NCT00408460
Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer treatment 2 completed NCT00040794
Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer treatment 2 completed NCT00087191
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer diagnostic Not Available terminated NCT00085280
Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer treatment Not Available completed NCT02059889
Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer No drug interventions diagnostic Not Available withdrawn NCT01971489
Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors treatment 1 withdrawn NCT00118144
Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer treatment 2 completed NCT00778167
Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00062101
Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer treatment 2 completed NCT01958372
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer treatment 1 completed NCT01383668
Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer treatment 1 withdrawn NCT00087412
S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer treatment 2 completed NCT01999881
Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients No drug interventions supportive_care Not Available completed NCT00738881
Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer treatment 3 terminated NCT00063895
Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck treatment 1 / 2 completed NCT01839955
Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer treatment 1 completed NCT01413750
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT03087708
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer supportive_care 2 terminated NCT00052338
Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer treatment 1 completed NCT05652868
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT05988697
Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib Not Available Not Available not_yet_recruiting NCT03647956
Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors treatment 2 unknown_status NCT00198432
Chemoradiotherapy of NSCLC Stage IIIB treatment 2 completed NCT03231475
Phase I Study of SPH1188-11 in NSCLC No drug interventions treatment 1 withdrawn NCT05816499
Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC) treatment 1 / 2 active_not_recruiting NCT05132218
Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT04042558
A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies treatment 2 recruiting NCT03594682
Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A Real World Exploratory Study No drug interventions treatment Not Available unknown_status NCT04768491
Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC Not Available Not Available recruiting NCT04467801
Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy treatment 2 recruiting NCT01864681
Combination of Metformin With Gefitinib to Treat NSCLC treatment 2 completed NCT04027647
Phase 2 Study of Dacomitinib in NSCLC treatment 2 active_not_recruiting NCT03515252
Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer No drug interventions treatment 1 completed NCT05281406
Additional Chemotherapy for EGFRm Patients With the Continued Presence of Plasma ctDNA EGFRm at Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG) treatment 2 recruiting NCT03805841
Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions treatment 2 terminated NCT04223596
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients treatment 2 active_not_recruiting NCT05212922
A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC treatment 2 withdrawn NCT06374160
Exercise in Patients With Advanced Non-small Cell Lung Cancer No drug interventions supportive_care Not Available not_yet_recruiting NCT03620669
1st Line Durvalumab in PS 2 NSCLC Patients treatment 2 active_not_recruiting NCT04865250
Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC treatment 2 recruiting NCT04932343
Comparison of Genomic and Transcriptomic Patterns Between CTC and Metastatic Tumormetastatic Tumor No drug interventions Not Available Not Available unknown_status NCT03368222
Pembrolizumab and SBRT in Metastatic Non-small-cell Lung Cancer Patients treatment 1 not_yet_recruiting